1092 related articles for article (PubMed ID: 17524398)
1. Exposure to human chorionic gonadotropin during in vitro maturation does not improve the maturation rate and developmental potential of immature oocytes from patients with polycystic ovary syndrome.
Ge HS; Huang XF; Zhang W; Zhao JZ; Lin JJ; Zhou W
Fertil Steril; 2008 Jan; 89(1):98-103. PubMed ID: 17524398
[TBL] [Abstract][Full Text] [Related]
2. Dual trigger with gonadotropin-releasing hormone agonist and standard dose human chorionic gonadotropin to improve oocyte maturity rates.
Griffin D; Feinn R; Engmann L; Nulsen J; Budinetz T; Benadiva C
Fertil Steril; 2014 Aug; 102(2):405-9. PubMed ID: 24842671
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of the efficiency between in-vitro maturation and in-vitro fertilization after early follicular phase GnRH agonist down-regulation in infertile women with polycystic ovary syndrome].
Zhu RR; Xiao SQ; Zhao JZ; Lin J; Wang PY; Jin CC; Jin WM
Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):833-7. PubMed ID: 24444560
[TBL] [Abstract][Full Text] [Related]
4. In-vitro maturation of oocytes vs in-vitro fertilization with a gonadotropin-releasing hormone antagonist for women with polycystic ovarian syndrome: can superiority be defined?
Shavit T; Ellenbogen A; Michaeli M; Kartchovsky E; Ruzov O; Shalom-Paz E
Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():46-50. PubMed ID: 24965979
[TBL] [Abstract][Full Text] [Related]
5. An improved IVM method for cumulus-oocyte complexes from small follicles in polycystic ovary syndrome patients enhances oocyte competence and embryo yield.
Sánchez F; Lolicato F; Romero S; De Vos M; Van Ranst H; Verheyen G; Anckaert E; Smitz JEJ
Hum Reprod; 2017 Oct; 32(10):2056-2068. PubMed ID: 28938744
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of the Levonorgestrel-Releasing Intrauterine System on IVF-ET Outcomes in PCOS With Simple Endometrial Hyperplasia.
Bian J; Shao H; Liu H; Li H; Fang L; Xing C; Wang L; Tao M
Reprod Sci; 2015 Jun; 22(6):758-66. PubMed ID: 25536958
[TBL] [Abstract][Full Text] [Related]
7. [Comparision of in vitro maturation applied in PCOS and non-PCOS patients undergo stimulated and unstimulated protocols].
Wang P; Zhao J; Jin C; Yu R; Lin J; Zhu R; Wu Y
Zhonghua Fu Chan Ke Za Zhi; 2014 Dec; 49(12):903-8. PubMed ID: 25608990
[TBL] [Abstract][Full Text] [Related]
8. Live birth after frozen-thawed oocytes matured in vitro in a PCOS patient: a model for improving implantation rates in IVM cycles and objectively assessing the real potential of development of frozen oocytes matured in vitro.
El Hachem H; Poulain M; Finet A; Fanchin R; Frydman N; Grynberg MH
Gynecol Endocrinol; 2014 Jun; 30(6):415-8. PubMed ID: 24576224
[TBL] [Abstract][Full Text] [Related]
9. Human Chorionic Gonadotropin Priming Does Not Improve Pregnancy Outcomes of PCOS-IVM Cycles.
Lin Y; Zheng X; Ma C; Li X; Zhang X; Yang P; Xu J; Zhu J
Front Endocrinol (Lausanne); 2020; 11():279. PubMed ID: 32425891
[No Abstract] [Full Text] [Related]
10. Structural and morphologic differences in human oocytes after in vitro maturation compared with standard in vitro fertilization.
Walls ML; Hart R; Keelan JA; Ryan JP
Fertil Steril; 2016 Nov; 106(6):1392-1398.e5. PubMed ID: 27565256
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of follicle-stimulating hormone priming and nonpriming in in vitro maturation of oocytes in infertile women with polycystic ovarian syndrome: a single-blinded randomized study.
Choavaratana R; Thanaboonyawat I; Laokirkkiat P; Prechapanich J; Suksompong S; Mekemaharn O; Petyim S
Gynecol Obstet Invest; 2015; 79(3):153-9. PubMed ID: 25503808
[TBL] [Abstract][Full Text] [Related]
12. Predictive factors for live birth after in vitro maturation of oocytes in women with polycystic ovary syndrome.
Tannus S; Hatirnaz S; Tan J; Ata B; Tan SL; Hatirnaz E; Kenat-Pektas M; Dahan MH
Arch Gynecol Obstet; 2018 Jan; 297(1):199-204. PubMed ID: 28993961
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo development of embryos produced by in vitro maturation and in vitro fertilization of cat oocytes.
Pope CE; McRae MA; Plair BL; Keller GL; Dresser BL
J Reprod Fertil Suppl; 1997; 51():69-82. PubMed ID: 9404273
[TBL] [Abstract][Full Text] [Related]
14. Use of gonadotropin-releasing hormone agonist trigger during in vitro fertilization is associated with similar endocrine profiles and oocyte measures in women with and without polycystic ovary syndrome.
O'Neill KE; Senapati S; Dokras A
Fertil Steril; 2015 Jan; 103(1):264-9. PubMed ID: 25450300
[TBL] [Abstract][Full Text] [Related]
15. Is elective single-embryo transfer a viable treatment policy in in vitro maturation cycles?
Hatırnaz S; Hatırnaz E; Dahan MH; Tan SL; Ozer A; Kanat-Pektas M; Ata B
Fertil Steril; 2016 Dec; 106(7):1691-1695. PubMed ID: 27678036
[TBL] [Abstract][Full Text] [Related]
16. In-vitro maturation versus IVF with GnRH antagonist for women with polycystic ovary syndrome: treatment outcome and rates of ovarian hyperstimulation syndrome.
Das M; Son WY; Buckett W; Tulandi T; Holzer H
Reprod Biomed Online; 2014 Nov; 29(5):545-51. PubMed ID: 25262236
[TBL] [Abstract][Full Text] [Related]
17. Progesterone levels on the day of human chorionic gonadotropin do not predict pregnancy outcome from the transfer of fresh or cryopreserved embryos from the same cohort.
Moffitt DV; Queenan JT; Shaw R; Muasher SJ
Fertil Steril; 1997 Feb; 67(2):296-301. PubMed ID: 9022606
[TBL] [Abstract][Full Text] [Related]
18. Prolonging oocyte in vitro culture and handling time does not compensate for a shorter interval from human chorionic gonadotropin administration to oocyte pickup.
Garor R; Shufaro Y; Kotler N; Shefer D; Krasilnikov N; Ben-Haroush A; Pinkas H; Fisch B; Sapir O
Fertil Steril; 2015 Jan; 103(1):72-5. PubMed ID: 25439844
[TBL] [Abstract][Full Text] [Related]
19. Effects of supplementation of the maturation media with insulin on in vitro maturation and in vitro fertilization of bovine oocytes.
Matsui M; Takahashi Y; Hishinuma M; Kanagawa H
Jpn J Vet Res; 1995 Dec; 43(3-4):145-53. PubMed ID: 8901031
[TBL] [Abstract][Full Text] [Related]
20. Reproductive outcomes after a single dose of gonadotropin-releasing hormone agonist compared with human chorionic gonadotropin for the induction of final oocyte maturation in hyper-responder women aged 35-40 years.
Tannus S; Turki R; Cohen Y; Son WY; Shavit T; Dahan MH
Fertil Steril; 2017 Jun; 107(6):1323-1328.e2. PubMed ID: 28501366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
